GSK
798 hedge funds and large institutions have $12.7B invested in GSK in 2021 Q2 according to their latest regulatory filings, with 95 funds opening new positions, 275 increasing their positions, 260 reducing their positions, and 64 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 774 → 798 (+24)
6% more repeat investments, than reductions
Existing positions increased: 275 | Existing positions reduced: 260
0.04% more ownership
Funds ownership: 5.04% → 5.08% (+0.04%)
Holders
798
Holding in Top 10
14
Calls
$241M
Puts
$173M
Top Buyers
| 1 | +$239M | |
| 2 | +$111M | |
| 3 | +$60.7M | |
| 4 |
Barclays
London,
United Kingdom
|
+$46.1M |
| 5 |
Goldman Sachs
New York
|
+$36.3M |
Top Sellers
| 1 | -$307M | |
| 2 | -$77.2M | |
| 3 | -$56.6M | |
| 4 |
Vontobel Holding
Zurich,
Switzerland
|
-$38.7M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$38.3M |